sacituzumab govitecan in patients with previously treated metastatic urothelial cancer
Published 5 years ago • 54 plays • Length 6:37Download video MP4
Download video MP3
Similar videos
-
7:14
ascent: sacituzumab govitecan vs treatment of physician’s choice in patients with previously tre...
-
5:01
sacituzumab govitecan in patients with previously treated muc
-
3:39
sacituzumab govitecan in previously treated metastatic urothelial carcinoma
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
4:25
trophy-u-01: sacituzumab govitecan in patients with muc after failure of platinum-based regimens...
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
3:53
sacituzumab govitecan in metastatic urothelial carcinoma: updates on the phase ii study
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
7:26
sacituzumab govitecan increases pfs for hr /her2‐ advanced breast cancer patients
-
3:59
sacituzumab govitecan increases pfs for hr /her2- metastatic breast cancer
-
4:34
neoadjuvant sacituzumab govitecan showed promising activity in muscle-invasive urothelial bladde...
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
1:10
use of sacituzumab govitecan in metastatic urothelial carcinoma
-
1:16
antibody-drug conjugates in advanced urothelial cancer: sacituzumab govitecan
-
2:38
trophy-u-01 cohort 3: sacituzumab govitecan pembrolizumab for patients with muc
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
0:40
neoadjuvant sacituzumab govitecan for muscle-invasive bladder cancer
-
1:38
dr. tagawa on sacituzumab govitecan in urothelial carcinoma